Cargando…
Six Laws of Open Source Drug Discovery
Six to swear by! Society needs effective and affordable medicines. We currently have at our disposal essentially one system to discover and develop drugs, and there are many areas where this system struggles to deliver, for example to combat antimicrobial resistance, or tropical diseases, or dementi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899868/ https://www.ncbi.nlm.nih.gov/pubmed/31612602 http://dx.doi.org/10.1002/cmdc.201900565 |
_version_ | 1783477227047878656 |
---|---|
author | Todd, Matthew H. |
author_facet | Todd, Matthew H. |
author_sort | Todd, Matthew H. |
collection | PubMed |
description | Six to swear by! Society needs effective and affordable medicines. We currently have at our disposal essentially one system to discover and develop drugs, and there are many areas where this system struggles to deliver, for example to combat antimicrobial resistance, or tropical diseases, or dementia. It is sensible to cultivate alternative, competing approaches to drug discovery and development. A genuinely new alternative is to open up the entire research cycle, abandoning secrecy altogether. This “open source” approach has now been trialed and the lessons learned distilled to six laws of operation that help to clarify working practices. This article examines and explains those laws, which can be adopted by anyone wishing to create medicines using an inclusive, public process.[Image: see text] |
format | Online Article Text |
id | pubmed-6899868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68998682019-12-19 Six Laws of Open Source Drug Discovery Todd, Matthew H. ChemMedChem Editorial Six to swear by! Society needs effective and affordable medicines. We currently have at our disposal essentially one system to discover and develop drugs, and there are many areas where this system struggles to deliver, for example to combat antimicrobial resistance, or tropical diseases, or dementia. It is sensible to cultivate alternative, competing approaches to drug discovery and development. A genuinely new alternative is to open up the entire research cycle, abandoning secrecy altogether. This “open source” approach has now been trialed and the lessons learned distilled to six laws of operation that help to clarify working practices. This article examines and explains those laws, which can be adopted by anyone wishing to create medicines using an inclusive, public process.[Image: see text] John Wiley and Sons Inc. 2019-10-15 2019-11-06 /pmc/articles/PMC6899868/ /pubmed/31612602 http://dx.doi.org/10.1002/cmdc.201900565 Text en © 2019 The Author. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Todd, Matthew H. Six Laws of Open Source Drug Discovery |
title | Six Laws of Open Source Drug Discovery |
title_full | Six Laws of Open Source Drug Discovery |
title_fullStr | Six Laws of Open Source Drug Discovery |
title_full_unstemmed | Six Laws of Open Source Drug Discovery |
title_short | Six Laws of Open Source Drug Discovery |
title_sort | six laws of open source drug discovery |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899868/ https://www.ncbi.nlm.nih.gov/pubmed/31612602 http://dx.doi.org/10.1002/cmdc.201900565 |
work_keys_str_mv | AT toddmatthewh sixlawsofopensourcedrugdiscovery |